Q1 Earnings Estimate for Chemours Issued By Zacks Research

The Chemours Company (NYSE:CC) – Research analysts at Zacks Research decreased their Q1 2025 earnings estimates for Chemours in a research report issued on Monday, March 3rd. Zacks Research analyst R. Department now forecasts that the specialty chemicals company will post earnings of $0.18 per share for the quarter, down from their prior forecast of $0.51. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q4 2025 earnings at $0.31 EPS, FY2025 earnings at $1.61 EPS, Q1 2026 earnings at $0.45 EPS, Q3 2026 earnings at $0.78 EPS and Q4 2026 earnings at $0.47 EPS.

A number of other research analysts also recently issued reports on the stock. BMO Capital Markets decreased their target price on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research report on Wednesday, February 19th. Barclays decreased their target price on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday, February 24th. Mizuho decreased their target price on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Royal Bank of Canada restated an “outperform” rating and set a $25.00 target price on shares of Chemours in a research report on Thursday, December 12th. Finally, The Goldman Sachs Group decreased their price objective on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $23.11.

Chemours Trading Down 0.7 %

NYSE CC opened at $14.00 on Thursday. The company has a market capitalization of $2.09 billion, a PE ratio of 24.56 and a beta of 1.81. The company has a fifty day moving average of $17.63 and a 200 day moving average of $18.73. Chemours has a 1 year low of $13.31 and a 1 year high of $29.21. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.00 annualized dividend and a dividend yield of 7.14%. Chemours’s dividend payout ratio (DPR) is presently 175.44%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of CC. GAMMA Investing LLC raised its position in shares of Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 765 shares during the last quarter. Truvestments Capital LLC acquired a new position in shares of Chemours during the 3rd quarter worth about $35,000. Brooklyn Investment Group purchased a new stake in Chemours during the 3rd quarter valued at about $37,000. Quadrant Capital Group LLC grew its stake in Chemours by 100.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 1,119 shares in the last quarter. Finally, Aster Capital Management DIFC Ltd purchased a new stake in Chemours during the 4th quarter valued at about $48,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.